Edwards Lifesciences (EW) Tops Q3 EPS by 8c; Issues Solid Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Edwards Lifesciences (EW) PT Lifted to $130 at Piper Jaffray on 'Spectacular' Q3
October 24, 2014 7:59 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Edwards Lifesciences (NYSE: EW) to $130.00 (from $120.00) following a "spectacular" Q3 beat on 44% underlying global TAVR sales growth with strength in both the US and OUS.
West commented,... More

